SCHEMBL17295405

SCHEMBL17295405

O=C1C(=Cc2ccc3[nH]cnc3c2)SC(=Nc2ccccc2)N1Cc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ CA9 Q16790 15/20 0.60
▸ CA2 P00918 2/20 0.60
▸ PTPN1 P18031 5/20 0.57
▸ ACP1 P24666 5/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17295403 1.00 CA9 (0.60) CA9CA2PTPN1ACP1
SCHEMBL17295441 0.89 LMNA (0.49) CA9CA2PTPN1ACP1
SCHEMBL17295442 0.89 LMNA (0.49) CA9CA2PTPN1ACP1
SCHEMBL17295528 0.89 ALDH1A1 (0.62) CA9CA2PTPN1ACP1
SCHEMBL17295526 0.89 ALDH1A1 (0.62) CA9CA2PTPN1ACP1
SCHEMBL17295388 0.88 FAAH (0.62) CA9CA2PTPN1ACP1
SCHEMBL17302192 0.88 FAAH (0.62) CA9CA2PTPN1ACP1
SCHEMBL17295632 0.86 LMNA (0.57) CA9CA2PTPN1
SCHEMBL17295631 0.86 LMNA (0.57) CA9CA2PTPN1
SCHEMBL17302139 0.83 MEN1 (0.59) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148990-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2017-04-05 — — EP disclosed
WO-2015181337-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2015-12-03 — — WO disclosed
Send feedback